These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29750671)

  • 1. Successful treatment of severe menorrhagia at menarche with recombinant factor VIIa in an adolescent girl with type III von Willebrand's disease.
    Gokcebay DG; Culha V; Yarali N; Ozbek NY
    Blood Coagul Fibrinolysis; 2018 Jul; 29(5):469-471. PubMed ID: 29750671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An inherited hemostatic disorder as the cause of menorrhagia].
    Leebeek FW; Lotgering FK
    Ned Tijdschr Geneeskd; 2002 Mar; 146(12):545-8. PubMed ID: 11938574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of Haemate-P in inherited von Willebrand's disease: a patient with type 3 VWD and recurrent menometrorrhagia.
    Dolatkhah R; Kermani IA; Sanaat Z; Seifi S; Ziaei JE; Nikanfar A; Esfehani A; Chavoushi SH
    Haemophilia; 2010 May; 16(3):555-7. PubMed ID: 20059558
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
    Majumdar G; Phillips JK; Lavallee H; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Therapy during Treatment of von Willebrand Disease.
    Favaloro EJ; Pasalic L; Curnow J
    Semin Thromb Hemost; 2017 Apr; 43(3):338-354. PubMed ID: 27472426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
    Abshire T; Cox-Gill J; Kempton CL; Leebeek FW; Carcao M; Kouides P; Donfield S; Berntorp E
    J Thromb Haemost; 2015 Sep; 13(9):1585-9. PubMed ID: 25930155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of von Willebrand's disease.
    Aledort LM
    Mayo Clin Proc; 1991 Aug; 66(8):841-6. PubMed ID: 1907343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of inherited bleeding disorders in women with menorrhagia.
    Kadir RA; Economides DL; Sabin CA; Owens D; Lee CA
    Lancet; 1998 Feb; 351(9101):485-9. PubMed ID: 9482440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand's disease: a prospective multi-centre study.
    Dunkley S; Baker RI; Pidcock M; Price J; Seldon M; Smith M; Street A; Maher D; Barrese G; Stone C; Lloyd J
    Haemophilia; 2010 Jul; 16(4):615-24. PubMed ID: 20331755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.
    Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A
    Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand's disease and menorrhagia: prevalence, diagnosis, and management.
    Kujovich JL
    Am J Hematol; 2005 Jul; 79(3):220-8. PubMed ID: 15981234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa.
    Meijer K; Peters FT; van der Meer J
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):211-3. PubMed ID: 11414636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
    Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
    Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis, clinical picture and treatment of von Willebrand's disease.
    Lethagen SR
    Ann Med; 1995 Dec; 27(6):641-51. PubMed ID: 8652143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand's disease: an important cause of dysfunctional uterine bleeding.
    Woo YL; White B; Corbally R; Byrne M; O'Connell N; O'Shea E; Sheppard BL; Bonnar J; Smith OP
    Blood Coagul Fibrinolysis; 2002 Mar; 13(2):89-93. PubMed ID: 11914650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor for menorrhagia: a survey and literature review.
    Ragni MV; Machin N; Malec LM; James AH; Kessler CM; Konkle BA; Kouides PA; Neff AT; Philipp CS; Brambilla DJ
    Haemophilia; 2016 May; 22(3):397-402. PubMed ID: 26843404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.